| 2025-06-06 |
13D/A |
STOK / Stoke Therapeutics, Inc. |
Blue Horizon Enterprise Ltd |
3,906,181 |
7.20 |
|
| 2025-06-05 |
13D |
ORIC / ORIC Pharmaceuticals, Inc. |
Sr One Capital Management, Llc |
4,615,384 |
5.40 |
|
| 2025-06-05 |
13D/A |
PROK / ProKidney Corp. |
Tolerantia, LLC |
106,901,339 |
36.50 |
-3.45 |
| 2025-06-04 |
13D/A |
UAN / CVR Partners, LP - Limited Partnership |
Icahn Enterprises Holdings L.p. |
4,164,274 |
39.40 |
0.00 |
| 2025-06-04 |
13D/A |
ELTX / Elicio Therapeutics, Inc. |
Gkcc, Llc |
9,764,864 |
48.00 |
74.53 |
| 2025-06-04 |
13D |
NBY / NovaBay Pharmaceuticals, Inc. |
Poplar Point Capital Management Llc |
1,020,300 |
17.54 |
5.01 |
| 2025-06-03 |
13D/A |
TSHA / Taysha Gene Therapies, Inc. |
Manning Paul B |
25,601,111 |
9.80 |
9.05 |
| 2025-06-03 |
13D/A |
HYPD / Hyperion DeFi, Inc. |
Avenue Venture Opportunities Fund, L.P. |
5,982,998 |
9.99 |
0.00 |
| 2025-06-03 |
13D/A |
PAHC / Phibro Animal Health Corporation |
BFI Co., LLC |
20,225,514 |
49.90 |
0.00 |
| 2025-06-03 |
13D |
ABVC / ABVC BioPharma, Inc. |
Eugene Jiang |
131,159 |
17.40 |
|
| 2025-06-02 |
13D/A |
SLSN / Solesence, Inc. |
Whitmore Bradford T |
49,826,805 |
71.00 |
0.00 |
| 2025-06-02 |
13D |
NKGN / NKGen Biotech, Inc. |
CFIC-2015 NV Family Investments, LLC |
63,175,321 |
47.20 |
1,416.21 |
| 2025-05-30 |
13D/A |
OKUR / OnKure Therapeutics, Inc. |
Acorn Bioventures, L.p. |
2,839,674 |
22.10 |
0.00 |
| 2025-05-29 |
13D/A |
PRTA / Prothena Corporation plc |
EcoR1 Capital, LLC |
0 |
0.00 |
-100.00 |
| 2025-05-28 |
13D |
ZURA / Zura Bio Limited |
AI Biotechnology LLC |
14,326,090 |
19.90 |
|
| 2025-05-28 |
13D/A |
OTLK / Outlook Therapeutics, Inc. |
GMS Ventures & Investments |
29,040,929 |
50.30 |
79.44 |
| 2025-05-28 |
13D |
PRQR / ProQR Therapeutics N.V. |
Van Herk Investments B.v. |
11,501,995 |
10.90 |
0.35 |
| 2025-05-27 |
13D/A |
BGM / BGM Group Ltd. |
AIX Inc. |
16,529,330 |
8.99 |
-76.39 |
| 2025-05-27 |
13D |
BGM / BGM Group Ltd. |
Low Thia Yang |
38,165,290 |
20.70 |
|
| 2025-05-23 |
13D |
RPRX / Royalty Pharma plc |
Legorreta G. Pablo |
103,112,796 |
19.74 |
|
| 2025-05-23 |
13D |
ATRA / Atara Biotherapeutics, Inc. |
Redmile Group, LLC |
705,207 |
9.90 |
17.29 |
| 2025-05-22 |
13D |
BCDA / BioCardia, Inc. |
Blank Andrew Scott |
278,253 |
5.50 |
|
| 2025-05-22 |
13D |
OKUR / OnKure Therapeutics, Inc. |
Acorn Bioventures, L.p. |
2,839,674 |
22.10 |
97.24 |
| 2025-05-22 |
13D/A |
INDV / Indivior PLC |
Two Seas Capital LP |
11,880,926 |
9.50 |
2.60 |
| 2025-05-21 |
13D/A |
BHC / Bausch Health Companies Inc. |
Paulson & Co. Inc. |
26,439,035 |
7.10 |
2.32 |
| 2025-05-21 |
13D/A |
BHC / Bausch Health Companies Inc. |
Icahn Partners Master Fund LP |
34,721,118 |
9.40 |
|
| 2025-05-21 |
13D/A |
BCDA / BioCardia, Inc. |
Daly Joseph Patrick |
|
|
|
| 2025-05-20 |
13D/A |
PLUR / Pluri Inc. |
Yanay Yaky |
484,866 |
6.00 |
-94.57 |
| 2025-05-20 |
13D/A |
MTVA / MetaVia Inc. |
Dong-a St Co., Ltd |
9,995,679 |
51.10 |
-14.63 |
| 2025-05-20 |
13D/A |
XOMA / XOMA Royalty Corporation |
Biotechnology Value Fund L P |
2,590,303 |
21.60 |
-13.17 |
| 2025-05-20 |
13D/A |
EXEL / Exelixis, Inc. |
Farallon Capital Partners, L.P. |
18,635,500 |
6.80 |
-20.50 |
| 2025-05-19 |
13D/A |
AURA / Aura Biosciences, Inc. |
Matrix Capital Management Company, LP |
6,922,870 |
11.17 |
0.00 |
| 2025-05-19 |
13D/A |
GLPG / Galapagos NV - Depositary Receipt (Common Stock) |
EcoR1 Capital, LLC |
7,803,202 |
11.84 |
10.00 |
| 2025-05-15 |
13D |
HYPD / Hyperion DeFi, Inc. |
Avenue Venture Opportunities Fund, L.P. |
5,982,998 |
67.90 |
|
| 2025-05-14 |
13D/A |
CRVS / Corvus Pharmaceuticals, Inc. |
Orbimed Advisors Llc |
9,785,423 |
12.20 |
0.00 |
| 2025-05-14 |
13D/A |
HOWL / Werewolf Therapeutics, Inc. |
Ra Capital Management, L.p. |
6,746,807 |
15.00 |
8.94 |
| 2025-05-14 |
13D/A |
BBIO / BridgeBio Pharma, Inc. |
KKR Genetic Disorder L.P. |
13,260,971 |
7.00 |
-31.15 |
| 2025-05-14 |
13D/A |
TNYA / Tenaya Therapeutics, Inc. |
Column Group Iii, Lp |
49,313,559 |
30.30 |
0.00 |
| 2025-05-14 |
13D |
TCRT / Alaunos Therapeutics, Inc. |
Pmgc Capital Llc |
83,500 |
5.09 |
|
| 2025-05-13 |
13D/A |
OLMA / Olema Pharmaceuticals, Inc. |
Logos Global Management LP |
3,208,875 |
4.70 |
-1.23 |
| 2025-05-13 |
13D/A |
PHAT / Phathom Pharmaceuticals, Inc. |
Frazier Life Sciences Public Fund, L.P. |
14,429,990 |
19.90 |
12.83 |
| 2025-05-13 |
13D/A |
ONC / BeOne Medicines AG - Depositary Receipt (Common Stock) |
Hillhouse Capital Advisors, Ltd. |
68,551,141 |
4.90 |
-26.13 |
| 2025-05-12 |
13D/A |
EWTX / Edgewise Therapeutics, Inc. |
Orbimed Advisors Llc |
15,252,867 |
14.50 |
3.37 |
| 2025-05-12 |
13D |
NKGN / NKGen Biotech, Inc. |
Paul Y. Song |
63,738,042 |
54.30 |
|
| 2025-05-12 |
13D/A |
ACLX / Arcellx, Inc. |
New Enterprise Associates 15, L.P. |
3,745,262 |
6.80 |
0.00 |
| 2025-05-12 |
13D/A |
KROS / Keros Therapeutics, Inc. |
ADAR1 Capital Management, LLC |
5,390,964 |
13.27 |
0.00 |
| 2025-05-12 |
13D/A |
LNZA / LanzaTech Global, Inc. |
Khosla Ventures III, L.P. |
62,867,361 |
25.00 |
46.66 |
| 2025-05-09 |
13D/A |
OSTX / OS Therapies Incorporated |
Auerbach Shalom |
2,687,570 |
9.90 |
-5.02 |
| 2025-05-09 |
13D/A |
GPRE / Green Plains Inc. |
Ancora Alternatives LLC |
5,844,715 |
8.70 |
34.65 |
| 2025-05-09 |
13D/A |
IVA / Inventiva S.A. - Depositary Receipt (Common Stock) |
Biotechnology Value Fund L P |
8,545,499 |
6.10 |
0.00 |
